Canada markets close in 5 hours 49 minutes

Novozymes A/S (NVZMF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
55.750.00 (0.00%)
As of 01:32PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close55.75
Open55.75
BidN/A x N/A
AskN/A x N/A
Day's Range55.75 - 55.75
52 Week Range38.85 - 55.77
Volume2,682
Avg. Volume2,724
Market Cap25.945B
Beta (5Y Monthly)0.48
PE Ratio (TTM)35.28
EPS (TTM)1.58
Earnings DateN/A
Forward Dividend & Yield1.46 (2.61%)
Ex-Dividend DateOct 11, 2023
1y Target EstN/A
  • GlobeNewswire

    Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed

    Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed February 2, 2024Company announcement No. 07 On January 29, 2024, following the satisfaction of all conditions precedent, the combination of Novozymes A/S ("Novozymes") and Chr. Hansen Holding A/S ("Chr. Hansen") by way of a statutory merger of the two companies (the "Combination") was successfully completed. Reference is made to Novozymes' company announcement no. 2 of January 29, 2024. As previously announ

  • GlobeNewswire

    Legacy Novozymes delivers solid last full-year results

    Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks the last financial reporting from legacy Novozymes, and the new company, Novonesis, is already a reality. COPENHAGEN, Denmark – February 1, 2024. In the 2023 financial year, legacy Novozymes delivers 5% organic sales growth – 6% organic sales growth in the fourth quarter alone – an EBIT-margin before specia

  • GlobeNewswire

    Results update for 2023 – unaudited

    6% organic sales growth in Q4 and 5% for the full year with solid margins and free cash flow generation As Novozymes just closed the combination with Chr. Hansen on January 29, and the annual report now is expected to be released on February 8, this announcement only contains unaudited numbers. Full audited financial statements as well as non-financial numbers will be released with the annual report on February 8. This result update allows us to provide selected numbers for Novozymes standalone